Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

57.54

+1.62

(+2.90%)

At close: 04:00PM EST

54.79

-2.75

(-4.78%)

After hours:

07:01PM EST

Loading interactive chart...

Zacks
Corcept Shares Rise More Than 60% in Three Months: Here's Why
CORT's Cushing's syndrome drug, Korlym, is driving revenues. The NDA for relacorilant in Cushing's syndrome will be filed shortly.
Zacks
3 Reasons Growth Investors Will Love Corcept (CORT)
Corcept (CORT) is well positioned to outperform the market, as it exhibits above-average growth in financials.